For the first time, an experimental drug shows promise for halting the progression of Alzheimer's disease by breaking up the protein tangles that clog victims' brains.
The new drug is in testing by a Singapore company. It's being praised for achieving the first positive results in maintaining the mental performance of Alzheimer's patients by using a novel approach.
Marcelle Morrison-Bogorad, of the National Institute on Aging, called it "just fantastic."
Preliminary results of a study of the drug were presented Tuesday at an Alzheimer's conference in Chicago. The drug, called Rember, is being developed by TauRx Therapeutics of Singapore.
KKTV firmly believes in freedom of speech for all and we are happy to provide this forum for the community to share opinions and facts. We ask that commenters keep it clean, keep it truthful, stay on topic and be responsible. Comments left here do not necessarily represent the viewpoint of KKTV 11 News.
If you believe that any of the comments on our site are inappropriate or offensive, please tell us by clicking “Report Abuse” and answering the questions that follow. We will review any reported comments promptly.powered by Disqus